Figure 2.
The recurrence-free survival in pheochromocytoma/paraganglioma patients (SDHB mutation patients versus SDHB wildtype patients; primary tumor size <5 versus primary tumor size ≥5cm; average Ki-67 count <3% versus Ki-67 count ≥3%).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.